Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Medapta Oy
OY
Active
Y-tunnus 2509259-7
Valimotie 7, 00380
Helsinki
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2012 · 13 years old
0 employees
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Medapta Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
3M
5M
8M
10M
7M
2021
9M
2022
-7M
2023
8M
2024
7M
2025
EBITDA
EUR millions
1M
1M
1M
0M
0M
1M
2021
1M
0%
2022
1M
0%
2023
1M
0%
2024
1M
0%
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
6 783
9 013
−7 220
8 300
7 181
Staff expenses
—
—
−0
−0
−0
EBITDA
640
894
925
831
1 049
Depreciation & amort.
−1
—
−0
−0
−0
EBIT
638
894
925
831
1 049
Net financials
−4
3
54
54
21
Profit before tax
130
181
1
1
0
Tax
127
179
0
0
0
Net profit
3
2
1
1
0
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
2 303
2 543
1 757
1 658
1 685
Equity
1 376
1 378
1 378
1 379
1 379
Long-term debt
0
—
0
0
0
Short-term debt
927
1 165
378
279
306
Total debt
927
1 165
378
279
306
Financial ratios
5-year trend
EBITDA margin
14.6%
This company
15.8%
Market median
-8% vs market
2021
2025
Equity ratio
81.8%
This company
38.2%
Market median
+114% vs market
2021
2025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
2021
2025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
2021
2025
Asset turnover
4.26×
This company
1.12×
Market median
+280% vs market
2021
2025
Debt / equity
0.22×
This company
0.62×
Market median
+65% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Medapta Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
